DLA Piper’s star co-head of mass tort and class actions Amy Schulman has left the firm to join Pfizer as general counsel and senior vice president, it was announced today (28 May).
Schulman is renowned as one of the US’s top litigators after a Harvard Business School case study in 2006 claimed that she was responsible for a $60m (£30.9m) book of business. Schulman is also believed to have been DLA Piper’s highest-paid partner in 2006, earning $5.75m (£2.96m) according to Legal Week‘s US sister title The American Lawyer.
